The foundation provided a volume guarantee to Novartis to reduce the price of oral polio virus vaccines in the developing world.
Investment Exit Year: 2012
Share this page:
The foundation provided a volume guarantee to Novartis to reduce the price of oral polio virus vaccines in the developing world.
Investment Exit Year: 2012